Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
{{output}}
The treatment options for metastatic non-small-cell lung cancer (NSCLC) have expanded dramatically in the last 10 years with the discovery of newer drugs and targeted therapy. Epidermal growth factor receptor (EGFR), when aberrantly activated, promotes cell gr... ...
